Neurobiology of DiseaseNeurosciencePeer-reviewed journal article
Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
Aurélien M. BadinaiD, Kelly CeyzériatiD, Quentin AmosséiD, Alexandre Tresh, Laurene AbjeaniD, Léa Guénat, Emilie Vauthey, Stergios TsartsalisiD, P. MilletiD, Benjamin B. TournieriD
Abstract
Alzheimers disease (AD) is characterized by cognitive decline and neuropathological hallmarks including A{beta} plaques and Tau tangles. Emerging evidence indicates oligodendrocyte (OL) dysfunction and demyelination also contribute to disease progression. Here, we analyzed OL markers and inflammatory gene expression in human hippocampal samples at early and late AD stages. In early AD, we observed OL and myelinating pathways downregulation, alongside microglial and astrocytic activation, as well as upregulated chemokine CCL2 and peripheral immune infiltration markers. In late stages, expression of OL-related genes and myelination pathways increase, with a higher NG2/MBP ratio, coinciding with decreased microglial coverage and peripheral immune markers. These findings indicate that early neuroinflammation may impair OL function, while attenuated immune activity in late AD allows partial OL recovery. This study provides insights into stage-specific inflammatory and myelin-related changes in AD, supporting the relevance of understanding oligodendrocyte dynamics and potential regenerative responses for future therapeutic strategies. HighlightsO_LIEarly AD: heightened microglial activation and peripheral infiltration. C_LIO_LILate AD: reduced microglial presence and oligodendrocyte partial recovery. C_LIO_LINeuroinflammation shifts toward remyelination-supporting conditions. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=190 HEIGHT=200 SRC="FIGDIR/small/645240v1_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@eb5f3forg.highwire.dtl.DTLVardef@ba239eorg.highwire.dtl.DTLVardef@7897feorg.highwire.dtl.DTLVardef@142a6fd_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 17
- FWCI
- 6.06
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Association of microglia loss with hippocampal network impairments as a turning point in the amyloid pathology progression.
Giusy Pizzirusso, Efthalia Preka, … Luis Enrique Arroyo‐García·bioRxiv·Mar 14, 2024
- Disrupted myelin homeostasis in grey matter of Alzheimer's disease
Assia Tiane, Emily Willems, … Tim Vanmierlo·bioRxiv·Jul 8, 2026
- Dynamic neuroinflammatory profiles predict Alzheimer's disease pathology in microglia-containing cerebral organoids
Madison K. Kuhn, Rachel Y. Kang, … Elizabeth A. Proctor·bioRxiv·Nov 16, 2023
- Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer's disease
Constanze Depp, Ting Sun, … Klaus‐Armin Nave·NaturePeer-reviewed·May 31, 2023
- The neuroinflammatory interleukin-12 signaling pathway drives Alzheimer's disease-like pathology by perturbing oligodendrocyte survival and neuronal homeostasis
Shirin Schneeberger, Seung Joon Kim, … Frank L. Heppner·bioRxiv·Apr 25, 2021
- Cytokine expression patterns predict suppression of vulnerable neural circuits in a mouse model of Alzheimer's disease
Dennis Chun Yin Chan, ChaeMin Kim, … Elizabeth A. Proctor·bioRxiv·Mar 17, 2024